Oddo BHF Asset Management Sas boosted its stake in Danaher Corporation (NYSE:DHR – Free Report) by 92.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 72,285 shares of the conglomerate’s stock after buying an additional 34,817 shares during the period. Oddo BHF Asset Management Sas’ holdings in Danaher were worth $16,547,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of DHR. Norges Bank acquired a new stake in Danaher in the 4th quarter valued at $2,177,106,000. Viking Global Investors LP boosted its stake in Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Danaher by 104.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after purchasing an additional 2,216,789 shares in the last quarter. Generation Investment Management LLP boosted its stake in Danaher by 34.0% in the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares in the last quarter. Finally, Capital International Investors boosted its stake in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Up 0.5%
DHR stock opened at $181.04 on Tuesday. The business has a 50-day moving average of $180.73 and a 200-day moving average of $204.27. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market capitalization of $128.13 billion, a P/E ratio of 35.02, a P/E/G ratio of 2.30 and a beta of 0.81.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on DHR shares. Guggenheim reduced their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. DZ Bank started coverage on Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. Piper Sandler assumed coverage on Danaher in a research note on Thursday. They issued a “neutral” rating and a $200.00 price objective on the stock. Finally, Jefferies Financial Group restated a “buy” rating and set a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- This Golden Cross Could Send Urban Outfitters to New Highs
- Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold?
- Can D-Wave Hold Its Own Against 2 Fast-Growing Rivals?
- 3 AI Stocks With Moats That Could Outlast Summer Volatility
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
